Australia markets closed

X4 Pharmaceuticals, Inc. (XFOR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2900+0.0600 (+4.88%)
At close: 04:00PM EDT
1.2799 -0.01 (-0.78%)
After hours: 07:43PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
3,000
Operating expenses
Research development
72,017
72,017
61,058
50,647
41,932
Selling general and administrative
35,505
35,505
27,020
24,702
20,942
Total operating expenses
107,522
107,522
88,078
75,349
62,874
Operating income or loss
-107,522
-107,522
-88,078
-75,349
-59,874
Interest expense
5,777
5,777
3,993
3,642
2,688
Total other income/expenses net
7,628
7,628
-1,987
-9,698
306
Income before tax
-101,089
-101,089
-93,839
-88,679
-61,983
Income tax expense
78
78
28
17
148
Income from continuing operations
-101,167
-101,167
-93,867
-88,696
-62,131
Net income
-101,167
-101,167
-93,867
-88,696
-62,131
Net income available to common shareholders
-101,167
-101,167
-96,413
-102,639
-62,131
Basic EPS
-0.68
-0.57
-1.52
-3.99
-3.09
Diluted EPS
-0.68
-0.57
-1.52
-3.99
-3.09
Basic average shares
153,357
177,812
63,526
25,749
20,077
Diluted average shares
153,357
177,812
63,526
25,749
20,077